Assure Holdings' Q2 case volume grows 36%

Marcus Robertson -  

Intraoperative neuromonitoring company Assure Holdings saw its second quarter 2022 managed case volume jump by about 36 percent year-over-year.

Assure's case volume for the full year is expected to grow by more than 40 percent, the company said Aug. 15. It expects a positive adjusted EBITDA in the second half of the year.

The company saw a second quarter net loss of $4.7 million, and a net loss per diluted share of $0.37, both steeper losses than over the same period in 2021.

"Given recent economic and capital markets uncertainty, Assure began a strategic cost-reduction effort that we expect will yield over $4.5 million of annualized savings," Assure's CEO and executive chair John Farlinger said in a company call. "As a result, we expect to become cash flow positive on an adjusted operating basis in the second half of 2022."

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Webinars

Featured Podcast

Featured Whitepapers